carbamazepine has been researched along with allopurinol in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.70) | 18.7374 |
1990's | 2 (2.70) | 18.2507 |
2000's | 13 (17.57) | 29.6817 |
2010's | 52 (70.27) | 24.3611 |
2020's | 5 (6.76) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Topliss, JG; Yoshida, F | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Badawy, AA; Morgan, CJ | 1 |
Alexopoulos, E; Chrisomalis, F; Karpouzas, J; Koukoudis, P; Papadimitriou, M; Papadopoulou, D; Sakellariou, G; Skenteris, N; Tsakaris, D | 1 |
Raasch, RH | 1 |
Chang, NC; Chen, YH; Dai, YS; Lin, MS; Pwu, RF | 1 |
Chen, YT; Chung, WH; Hung, SI | 1 |
Hashimoto, K; Tohyama, M | 1 |
Chang, YC; Chiou, CC; Chung, WH; Ho, HC; Hong, HS; Hu, S; Hung, SI; Kuo, TT; Yang, LC | 1 |
Asano, Y; Hirahara, K; Kano, Y; Shiohara, T | 1 |
Jin, DK; Kim, SJ; Paik, KH; Park, SW; Sohn, YB | 1 |
Broadfoot, AJ; Fernando, SL | 1 |
Aouam, K; Ben Fredj, N; Ben Rhomdhane, F; Boughattas, N; Chaabane, A; Chakroun, M; Toumi, A | 1 |
Chung, WH; Hung, SI | 1 |
Arhan, E; Kurt, N; Kutsal, E; Ozcelik, A; Ozturk, B; Ozturk, HS; Serdaroglu, A; Sevinc, N | 1 |
Kaniwa, N | 1 |
Aihara, M | 1 |
Cacoub, P; Descamps, V; Finzi, L; Meyer, O; Musette, P; Roujeau, JC; Speirs, C | 1 |
Bharadwaj, M; Illing, P; McCluskey, J; Purcell, AW; Rossjohn, J; Theodossis, A | 1 |
Eckels, D; Profaizer, T | 1 |
Barbaud, A; Bollaert, M; Gastin, I; Jeulin, H; Rabaud, C; Schmutz, JL; Tréchot, P; Waton, J | 1 |
Pirmohamed, M | 1 |
Adam, J; Pichler, WJ; Yerly, D; Yun, J | 1 |
Daghfous, R; El Fekih, N; Fazaa, B; Khaled, A; Souissi, A; Zeglaoui, F | 1 |
Kaniwa, N; Saito, Y | 1 |
Chao, L; Mei, H; Pan, XC; Tan, W; Wang, Q; Zhang, YL | 1 |
Karlin, E; Phillips, E | 1 |
Borroni, RG | 1 |
Chen, CH; Chen, WL; Cheng, CY; Chung, WH; Deng, ST; Su, SC | 1 |
Chen, X; Xiong, Y; Zhang, W | 1 |
Chaikledkaew, U; Chantratita, W; Lee, MT; Mahasirimongkol, S; Patrinos, GP; Pavlidis, C; Suwankesawong, W; Zhang, Y | 1 |
Bastuji-Garin, S; Chosidow, O; de Feraudy, S; Delfau-Larue, MH; Duong, TA; Ortonne, N; Roujeau, JC; Valeyrie-Allanore, L; Wechsler, J; Wolkenstein, P | 1 |
Chen, SA; Fu, X; Luo, X; Ma, L; Meng, C; Sun, X; Xing, Q; Xu, J; Yan, S; Yang, F; Yang, Y; Zhu, Q | 1 |
Chung, WH; Hung, SI; Mallal, S; Phillips, EJ; White, KD | 1 |
Kim, DH; Kim, J; Kim, YJ; Lee, JH; Park, HJ; Park, JW; Park, KH | 1 |
Kinoshita, Y; Saeki, H | 1 |
Chung, WH; Dao, RL; Fan, WL; Hung, SI; Su, SC | 1 |
Becquemont, L; Negrini, S | 1 |
Adler, NR; Aung, AK; Ergen, EN; Goh, MSY; Phillips, EJ; Trubiano, J | 1 |
Fricke-Galindo, I; LLerena, A; López-López, M | 1 |
Li, M; Wang, F; Zhang, X; Zhao, YK; Zhu, Z | 1 |
Aw, D; Chan, CL; Chong, YY; Dong, D; Koay, ES; Lateef, A; Lee, EJ; Lee, HY; Lee, SX; Lim, YL; Limenta, M; Loke, C; Lui, NL; Pang, SM; Ren, EC; Sung, C; Tan, L; Tan-Koi, WC; Tay, YK; Toh, D; Vasudevan, A | 1 |
Illing, PT; McCluskey, J; Purcell, AW | 1 |
Ha, JW; Hahm, JE; Kim, CW; Kim, SS; Lee, JY; Lee, SY | 1 |
Chen, S; Gao, X; Luo, X; Wu, X; Xing, Q; Xiong, H; Yang, F; Zhu, Q | 1 |
Dimas, K; Gerogianni, K; Tsezou, A | 1 |
Cheng, CY; Cheng, FJ; Chuang, PC; Huang, YS; Pan, HY; Syu, FK | 1 |
Chen, S; Jiang, M; Luo, X; Qin, S; Tang, C; Wang, L; Xing, Q; Xiong, H; Yang, F; Zhu, H; Zhu, Q | 1 |
Kang, DY; Kang, HR; Kang, MG; Lee, JY; Park, HK; Sohn, KH; Yang, MS | 1 |
Chan, FL; Dodiuk-Gad, RP; Hashimoto, R; Maharaj, A; Olteanu, C; Shear, NH; Ziv, M | 1 |
Nakamura, R; Saito, Y | 1 |
Krebs, K; Lauschke, VM; Milani, L; Zhou, Y | 1 |
Choi, JH; Hur, GY; Jee, YK; Jeong, JW; Jeong, YY; Jin, HJ; Jung, JW; Kang, DY; Kang, HR; Kang, MG; Kim, CW; Kim, HK; Kim, JH; Kim, MH; Kim, MS; Kim, MY; Kim, S; Kim, SH; Koh, YI; Kwon, YE; La, HO; Lee, J; Lee, JK; Lee, SE; Lee, SM; Lee, SY; Lee, YW; Nam, YH; Park, CS; Park, HK; Park, JW; Park, SJ; Sim, DW; Yang, MS; Ye, YM; Yun, J | 1 |
Brett, AS; Goodman, CW | 1 |
Chen, WW; Chien, MY; Chiou, MH; Chu, CY; Huang, PW | 1 |
Chen, C; Chen, X; Chi, L; Guo, X; Guo, Z; He, J; Liang, J; Wei, L; Ye, X; Zheng, Y; Zhou, W | 1 |
26 review(s) available for carbamazepine and allopurinol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Human leukocyte antigens and drug hypersensitivity.
Topics: Allopurinol; Carbamazepine; Dideoxynucleosides; Drug Eruptions; Drug Hypersensitivity; Genetic Predisposition to Disease; HLA Antigens; HLA-B Antigens; Humans; Pharmacogenetics; Stevens-Johnson Syndrome | 2007 |
[Drug-induced hypersensitivity syndrome: DIHS].
Topics: Allopurinol; Anticonvulsants; Carbamazepine; Drug Eruptions; Drug Hypersensitivity; Herpesvirus 6, Human; Humans; Solvents; Sulfasalazine; Syndrome; T-Lymphocytes; Trichloroethylene; Virus Activation | 2007 |
Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
Topics: Allopurinol; Apoptosis; Biomarkers; Carbamazepine; Cytotoxicity, Immunologic; Genetic Predisposition to Disease; Granzymes; HLA-B Antigens; HLA-B15 Antigen; Humans; Keratinocytes; Killer Cells, Natural; Polymorphism, Genetic; Stevens-Johnson Syndrome; T-Lymphocytes, Cytotoxic | 2010 |
[Exploratory study on biomarkers associated with severe cutaneous adverse reactions].
Topics: Allopurinol; Carbamazepine; HLA-B Antigens; Humans; Pharmacogenetics; Racial Groups; Stevens-Johnson Syndrome; T-Lymphocytes | 2011 |
Pharmacogenetics of cutaneous adverse drug reactions.
Topics: Allopurinol; Anti-Retroviral Agents; Anticonvulsants; Asian People; Carbamazepine; Drug Eruptions; Enzyme Inhibitors; HLA-B Antigens; Humans; Pharmacogenetics; Stevens-Johnson Syndrome; White People | 2011 |
The DRESS syndrome: a literature review.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Allopurinol; Carbamazepine; Diagnosis, Differential; Drug Eruptions; Eosinophilia; Exanthema Subitum; Female; Fever; Herpesvirus 6, Human; Humans; Lymphatic Diseases; Male; Middle Aged; Syndrome; Treatment Outcome | 2011 |
Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
Topics: Alleles; Allopurinol; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; HLA Antigens; Humans; Major Histocompatibility Complex; Pharmacogenetics; Polymorphism, Genetic; T-Lymphocytes | 2012 |
HLA alleles and drug hypersensitivity reactions.
Topics: Alleles; Allopurinol; Anti-HIV Agents; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Gene Frequency; Genetic Testing; HLA-B Antigens; HLA-B15 Antigen; Humans; Pharmacogenetics; Stevens-Johnson Syndrome | 2012 |
Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA.
Topics: Alleles; Allopurinol; Carbamazepine; Drug Hypersensitivity; HLA Antigens; HLA-B Antigens; Humans; Receptors, Antigen, T-Cell; T-Lymphocytes | 2012 |
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Topics: Alleles; Allopurinol; Amoxicillin-Potassium Clavulanate Combination; Azetidines; Benzylamines; Carbamazepine; Chemical and Drug Induced Liver Injury; Diclofenac; Dideoxynucleosides; Drug Hypersensitivity; Floxacillin; Genetic Markers; HLA Antigens; HLA-A Antigens; HLA-B Antigens; HLA-DQ alpha-Chains; Humans; Lapatinib; Pharmacogenetics; Quinazolines; Skin; Stevens-Johnson Syndrome; Ticlopidine | 2013 |
[The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
Topics: Alleles; Allopurinol; Anti-HIV Agents; Anticonvulsants; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity Syndrome; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Genome-Wide Association Study; HLA Antigens; HLA-B Antigens; HLA-B15 Antigen; Humans; Stevens-Johnson Syndrome | 2013 |
Genotyping for severe drug hypersensitivity.
Topics: Allopurinol; Amoxicillin-Potassium Clavulanate Combination; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Genotype; HLA-B Antigens; Humans; Nevirapine; Pharmacogenetics; Protein Conformation; Stevens-Johnson Syndrome | 2014 |
Pharmacogenetic markers of severe cutaneous adverse drug reactions.
Topics: Allopurinol; Anti-HIV Agents; Anticonvulsants; Biomarkers; Carbamazepine; Dideoxynucleosides; Drug Eruptions; Drug Hypersensitivity Syndrome; Enzyme Inhibitors; Genes, MHC Class I; Genome-Wide Association Study; Genotype; HLA Antigens; Humans; Nevirapine; Pharmacogenetics; Polymorphism, Single Nucleotide; Stevens-Johnson Syndrome | 2014 |
HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.
Topics: Alleles; Allopurinol; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity Syndrome; Gene Expression; Genetic Predisposition to Disease; HLA Antigens; Humans; Stevens-Johnson Syndrome; T-Lymphocytes | 2014 |
[Pharmacogenetic research in the association between human leukocyte antigen and adverse drug reactions].
Topics: Allopurinol; Carbamazepine; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Genome-Wide Association Study; HLA Antigens; Humans; Pharmacogenetics | 2014 |
Clinical application of pharmacogenomics: the example of HLA-based drug-induced toxicity.
Topics: Acute Generalized Exanthematous Pustulosis; Alleles; Allopurinol; Anticonvulsants; Antimetabolites; Asian People; Carbamazepine; Drug Hypersensitivity Syndrome; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Pharmacogenetics; Polymorphism, Genetic; Stevens-Johnson Syndrome | 2014 |
Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
Topics: Allopurinol; B-Lymphocytes; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Gene Expression Regulation; Genetic Loci; HLA Antigens; Humans; Models, Immunological; Pharmacogenetics; Stevens-Johnson Syndrome; T-Lymphocytes; Virus Diseases | 2015 |
A review of toxic epidermal necrolysis management in Japan.
Topics: Allopurinol; Carbamazepine; Female; HLA-B Antigens; HLA-B15 Antigen; Humans; Japan; Male; Stevens-Johnson Syndrome; Sulfonamides | 2017 |
Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation.
Topics: Allopurinol; Anti-HIV Agents; Anticonvulsants; Biomarkers; Carbamazepine; Dideoxynucleosides; Genetic Markers; Gout Suppressants; HLA-B Antigens; Humans; Inactivation, Metabolic; Pharmacogenetics; Precision Medicine; Prognosis; Safety-Based Drug Withdrawals; Stevens-Johnson Syndrome | 2016 |
Pharmacogenetics of hypersensitivity drug reactions.
Topics: Allopurinol; Anticonvulsants; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Enzyme Inhibitors; Genetic Predisposition to Disease; HLA Antigens; Humans; Pharmacogenetics; Reverse Transcriptase Inhibitors | 2017 |
Recent advances in the understanding of severe cutaneous adverse reactions.
Topics: Allopurinol; Anticonvulsants; beta-Lactams; Carbamazepine; Cephalosporins; Dideoxynucleosides; Drug Eruptions; Drug Interactions; Herpesviridae Infections; Humans; Leukocytes, Mononuclear; Pharmacogenetics; Prospective Studies; Skin Tests; T-Lymphocytes; Virus Activation; Virus Latency | 2017 |
An update on HLA alleles associated with adverse drug reactions.
Topics: Alleles; Allopurinol; Carbamazepine; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Economics, Pharmaceutical; HLA Antigens; Humans; Nevirapine | 2017 |
The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions.
Topics: Allopurinol; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Haptens; HLA Antigens; Humans; Pharmacogenetics; Polymorphism, Genetic | 2017 |
Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.
Topics: Alleles; Allopurinol; Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Carbamazepine; Dideoxynucleosides; Drug Hypersensitivity; Gene Expression; Genetic Testing; Gout Suppressants; HLA-B Antigens; Humans; Pharmacogenetics; Skin | 2018 |
[Mechanisms of Severe Cutaneous Adverse Reactions and a New Treatment Strategy].
Topics: Acetaminophen; Adrenal Cortex Hormones; Allopurinol; Antigens, Differentiation, T-Lymphocyte; Carbamazepine; CD8-Positive T-Lymphocytes; Cyclosporine; Epidermis; Etanercept; Fas Ligand Protein; HLA Antigens; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Japan; Lamotrigine; Plasma Exchange; Stevens-Johnson Syndrome; Tumor Necrosis Factor-alpha | 2019 |
2 trial(s) available for carbamazepine and allopurinol
Article | Year |
---|---|
Effects of epilepsy and antiepileptic drugs on nitric oxide, lipid peroxidation and xanthine oxidase system in children with idiopathic epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Lipid Peroxidation; Male; Nitric Oxide; Oxcarbazepine; Valproic Acid; Xanthine Oxidase | 2011 |
Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.
Topics: Allopurinol; Carbamazepine; Female; High-Throughput Nucleotide Sequencing; Humans; Male; Methazolamide; Receptors, Antigen, T-Cell, alpha-beta; Stevens-Johnson Syndrome | 2019 |
46 other study(ies) available for carbamazepine and allopurinol
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of acute carbamazepine administration on haem metabolism in rat liver.
Topics: 5-Aminolevulinate Synthetase; Allopurinol; Animals; Carbamazepine; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Enzyme Induction; Heme; Indoleamine-Pyrrole 2,3,-Dioxygenase; Liver; Male; Porphyrias; Rats; Rats, Inbred Strains; Tryptophan Oxygenase | 1992 |
Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN).
Topics: Aged; Allopurinol; Amoxicillin; Carbamazepine; Child; Ciprofloxacin; Humans; Male; Mefenamic Acid; Middle Aged; Plasma Exchange; Skin; Stevens-Johnson Syndrome; Tetanus Toxoid | 1991 |
Interactions of oral antibiotics and common chronic medications.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Allopurinol; Ampicillin; Antacids; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Digoxin; Drug Combinations; Drug Interactions; Erythromycin; Humans; Sulfamethoxazole; Sulfonamides; Sulfonylurea Compounds; Tetracycline; Theophylline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin | 1987 |
Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
Topics: Adult; Allopurinol; Analgesics, Non-Narcotic; Anticonvulsants; Antimetabolites; Carbamazepine; Case-Control Studies; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Phenytoin; Risk Assessment; Stevens-Johnson Syndrome; Taiwan | 2005 |
Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan.
Topics: Adolescent; Adult; Aged; Allopurinol; Carbamazepine; Eosinophilia; Exanthema; Female; Humans; Hydrocortisone; Male; Middle Aged; Prednisolone; Prognosis; Taiwan; Treatment Outcome | 2008 |
HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions.
Topics: Alleles; Allopurinol; Anticonvulsants; Asian People; Carbamazepine; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Gout Suppressants; HLA-B Antigens; Humans; Japan; Stevens-Johnson Syndrome; Syndrome; Virus Activation | 2008 |
Chronic peritoneal dialysis in a 4-year-old boy with Lesch-Nyhan disease.
Topics: Allopurinol; Carbamazepine; Child, Preschool; DNA Mutational Analysis; Erythrocytes; Family Health; Female; Gout Suppressants; Humans; Hypoxanthine Phosphoribosyltransferase; Intellectual Disability; Lesch-Nyhan Syndrome; Male; Mutation; Peritoneal Dialysis; Treatment Outcome | 2009 |
Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.
Topics: Adult; Alleles; Allopurinol; Anticonvulsants; Asian People; Carbamazepine; China; Cyclosporine; Drug Hypersensitivity; Genetic Predisposition to Disease; Genetic Testing; Gout Suppressants; HLA-B Antigens; Humans; Immunization, Passive; Immunosuppressive Agents; Keratoconjunctivitis; Male; Stevens-Johnson Syndrome; Urethritis | 2010 |
Hypersensitivity to amoxicillin after drug rash with eosinophilia and systemic symptoms (DRESS) to carbamazepine and allopurinol: a possible co-sensitization.
Topics: Adult; Allopurinol; Amoxicillin; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Drug Hypersensitivity; Enzyme Inhibitors; Eosinophilia; Exanthema; Humans; Male; Middle Aged | 2010 |
[Six cases of spring DRESS].
Topics: Acute Kidney Injury; Adult; Aged; Allopurinol; Amoxicillin; Anti-Bacterial Agents; Carbamazepine; Chemical and Drug Induced Liver Injury; Cytomegalovirus; Cytomegalovirus Infections; Disease Outbreaks; Drug Eruptions; Epstein-Barr Virus Infections; Female; France; Herpesvirus 4, Human; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Hypereosinophilic Syndrome; Imidazoles; Immunocompromised Host; Male; Middle Aged; Models, Biological; Roseolovirus Infections; Seasons; Trimethoprim, Sulfamethoxazole Drug Combination; Virus Activation | 2012 |
Genetics and the potential for predictive tests in adverse drug reactions.
Topics: Allopurinol; Anti-Bacterial Agents; Anti-HIV Agents; Anticonvulsants; Antimetabolites; Biomarkers; Carbamazepine; Chemical and Drug Induced Liver Injury; Dideoxynucleosides; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Genome-Wide Association Study; HLA Antigens; HLA-A Antigens; HLA-B Antigens; Humans; Immune System; Predictive Value of Tests; Stevens-Johnson Syndrome | 2012 |
[DRESS syndrome].
Topics: Adolescent; Adult; Allopurinol; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Carbamazepine; Child; Drug Combinations; Drug Eruptions; Eosinophilia; Exanthema; Female; Glucosamine; Gout Suppressants; Humans; Male; Middle Aged; Pruritus; Retrospective Studies; Sulfasalazine; Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2012 |
Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Bacterial Agents; B-Lymphocytes; Carbamazepine; Drug Hypersensitivity Syndrome; Exanthema; Female; Gout Suppressants; Humans; Immunohistochemistry; Male; Middle Aged; Minocycline; Phenotype; Retrospective Studies; Sulfasalazine; T-Lymphocytes; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2015 |
Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans.
Topics: Allopurinol; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Asian People; Biomarkers; Carbamazepine; Carbonic Anhydrase Inhibitors; Case-Control Studies; Cephalosporins; China; Cytokines; Drug Eruptions; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotyping Techniques; Gout Suppressants; HLA-B Antigens; Humans; Methazolamide; Polymorphism, Single Nucleotide; Sulfasalazine | 2015 |
HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
Topics: Adult; Aged; Alleles; Allopurinol; Anticonvulsants; Asian People; Carbamazepine; Case-Control Studies; Drug-Related Side Effects and Adverse Reactions; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; HLA-B Antigens; Humans; Lamotrigine; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Republic of Korea; Retrospective Studies; Risk Factors; Stevens-Johnson Syndrome; Triazines | 2016 |
Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Carbamazepine; Cephalosporins; Child; Child, Preschool; China; Drug Eruptions; Female; Fluoroquinolones; Humans; Infant; Male; Medicine, Chinese Traditional; Middle Aged; Penicillins; Young Adult | 2017 |
Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.
Topics: Alleles; Allopurinol; Carbamazepine; Cost-Benefit Analysis; Drug-Related Side Effects and Adverse Reactions; HLA-B Antigens; Humans; Pharmacogenetics; Singapore; Skin; Skin Diseases | 2017 |
Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anticonvulsants; Antitubercular Agents; Carbamazepine; Drug Hypersensitivity Syndrome; Eosinophilia; Female; Glucocorticoids; Gout Suppressants; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Methylprednisolone; Middle Aged; Prednisone; Republic of Korea; Retrospective Studies; Severity of Illness Index; Thrombocytopenia; Time Factors; Young Adult | 2017 |
Clinical, Viral and Genetic Characteristics of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in Shanghai, China.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Allopurinol; Carbamazepine; China; DNA, Viral; Drug Hypersensitivity Syndrome; Female; Genetic Predisposition to Disease; Herpesvirus 4, Human; Herpesvirus 6, Human; HLA-B Antigens; HLA-DRB1 Chains; Hospital Costs; Humans; Immunoglobulins, Intravenous; Length of Stay; Male; Middle Aged; Patient Admission; Phenotype; Retrospective Studies; Risk Factors; Sulfasalazine; Time Factors; Virus Activation; Young Adult | 2018 |
Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
Topics: Adult; Aged; Allopurinol; Anticonvulsants; Carbamazepine; Case-Control Studies; Drug Combinations; Epilepsy; Female; Gout; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Phenytoin; Stevens-Johnson Syndrome; Taiwan | 2018 |
Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea.
Topics: Adverse Drug Reaction Reporting Systems; Allopurinol; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Drug Labeling; Female; Humans; Male; Middle Aged; Republic of Korea; Skin Diseases; Stevens-Johnson Syndrome | 2019 |
Knowledge and opinions among Canadian academic physicians regarding genetic screening to prevent severe cutaneous adverse drug reactions.
Topics: Academies and Institutes; Allopurinol; Attitude of Health Personnel; Canada; Carbamazepine; Drug Eruptions; Genetic Testing; Health Knowledge, Attitudes, Practice; Humans; Severity of Illness Index; Stevens-Johnson Syndrome | 2019 |
Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost-Effectiveness of Preemptive Pharmacogenetic Testing.
Topics: Alleles; Allopurinol; Asia; Carbamazepine; Cost-Benefit Analysis; Dideoxynucleosides; Drug Hypersensitivity; Europe; Genetic Testing; Genotype; HLA Antigens; Humans; Pharmacogenetics; Pharmacogenomic Testing | 2021 |
A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea.
Topics: Allopurinol; Carbamazepine; Humans; Registries; Republic of Korea; Stevens-Johnson Syndrome | 2021 |
Race and Pharmacogenomics-Personalized Medicine or Misguided Practice?
Topics: Allopurinol; Asian People; Carbamazepine; Genetic Testing; HLA-B Antigens; HLA-B15 Antigen; Humans; Pharmacogenetics; Precision Medicine; Racial Groups; United States; United States Food and Drug Administration | 2021 |
Analysis of severe cutaneous adverse reactions (SCARs) in Taiwan drug-injury relief system: 18-year results.
Topics: Allopurinol; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Carbamazepine; Cicatrix; Humans; Phenytoin; Retrospective Studies; Stevens-Johnson Syndrome; Taiwan | 2022 |
Drug-induced Stevens-Johnson syndrome: a disproportionality analysis from the pharmacovigilance database of the World Health Organization.
Topics: Allopurinol; Carbamazepine; Humans; Pharmacovigilance; Phenytoin; Retrospective Studies; Stevens-Johnson Syndrome; World Health Organization | 2022 |